Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil

Different countries have adopted strategies for the early detection of SARS-CoV-2 since the declaration of community transmission by the World Health Organization (WHO) and timely diagnosis has been considered one of the major obstacles for surveillance and healthcare. Here, we report the increase o...

Descripción completa

Detalles Bibliográficos
Autores principales: Grotto, Rejane Maria Tommasini, Santos Lima, Rodrigo, de Almeida, Gabriel Berg, Ferreira, Claudia Pio, Guimarães, Raul Borges, Pronunciate, Micheli, Azevedo, Edmur, Catão, Rafael de Castro, Fortaleza, Carlos Magno Castelo Branco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
From the Field
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477464/
https://www.ncbi.nlm.nih.gov/pubmed/32807244
http://dx.doi.org/10.1017/S0950268820001818
_version_ 1783579906097020928
author Grotto, Rejane Maria Tommasini
Santos Lima, Rodrigo
de Almeida, Gabriel Berg
Ferreira, Claudia Pio
Guimarães, Raul Borges
Pronunciate, Micheli
Azevedo, Edmur
Catão, Rafael de Castro
Fortaleza, Carlos Magno Castelo Branco
author_facet Grotto, Rejane Maria Tommasini
Santos Lima, Rodrigo
de Almeida, Gabriel Berg
Ferreira, Claudia Pio
Guimarães, Raul Borges
Pronunciate, Micheli
Azevedo, Edmur
Catão, Rafael de Castro
Fortaleza, Carlos Magno Castelo Branco
author_sort Grotto, Rejane Maria Tommasini
collection PubMed
description Different countries have adopted strategies for the early detection of SARS-CoV-2 since the declaration of community transmission by the World Health Organization (WHO) and timely diagnosis has been considered one of the major obstacles for surveillance and healthcare. Here, we report the increase of the number of laboratories to COVID-19 diagnosis in Brazil. Our results demonstrate an increase and decentralisation of certified laboratories, which does not match the much higher increase in the number of COVID-19 cases. Also, it becomes clear that laboratories are irregularly distributed over the country, with a concentration in the most developed state, São Paulo.
format Online
Article
Text
id pubmed-7477464
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-74774642020-09-08 Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil Grotto, Rejane Maria Tommasini Santos Lima, Rodrigo de Almeida, Gabriel Berg Ferreira, Claudia Pio Guimarães, Raul Borges Pronunciate, Micheli Azevedo, Edmur Catão, Rafael de Castro Fortaleza, Carlos Magno Castelo Branco Epidemiol Infect From the Field Different countries have adopted strategies for the early detection of SARS-CoV-2 since the declaration of community transmission by the World Health Organization (WHO) and timely diagnosis has been considered one of the major obstacles for surveillance and healthcare. Here, we report the increase of the number of laboratories to COVID-19 diagnosis in Brazil. Our results demonstrate an increase and decentralisation of certified laboratories, which does not match the much higher increase in the number of COVID-19 cases. Also, it becomes clear that laboratories are irregularly distributed over the country, with a concentration in the most developed state, São Paulo. Cambridge University Press 2020-08-18 /pmc/articles/PMC7477464/ /pubmed/32807244 http://dx.doi.org/10.1017/S0950268820001818 Text en © The Author(s) 2020 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle From the Field
Grotto, Rejane Maria Tommasini
Santos Lima, Rodrigo
de Almeida, Gabriel Berg
Ferreira, Claudia Pio
Guimarães, Raul Borges
Pronunciate, Micheli
Azevedo, Edmur
Catão, Rafael de Castro
Fortaleza, Carlos Magno Castelo Branco
Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil
title Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil
title_full Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil
title_fullStr Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil
title_full_unstemmed Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil
title_short Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil
title_sort increasing molecular diagnostic capacity and covid-19 incidence in brazil
topic From the Field
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477464/
https://www.ncbi.nlm.nih.gov/pubmed/32807244
http://dx.doi.org/10.1017/S0950268820001818
work_keys_str_mv AT grottorejanemariatommasini increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT santoslimarodrigo increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT dealmeidagabrielberg increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT ferreiraclaudiapio increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT guimaraesraulborges increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT pronunciatemicheli increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT azevedoedmur increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT cataorafaeldecastro increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil
AT fortalezacarlosmagnocastelobranco increasingmoleculardiagnosticcapacityandcovid19incidenceinbrazil

Ejemplares similares